Well there’s the issue of patents and markets The PCSK9.. Inclirisan… is patent protected in both EU and US markets plus ROW It’s not really a statin add on … its promise is as a better option to statin therapy
The idea behind Inclirisan is that its 2 shots a year to basically cut your LDL cholesterol in half One shot when U get your annual flu shot and another 6 mths later in a clinic
Problem right now is cost The first year you need 3 shots priced at around $3K each . Then following years is 2 shots …. $6k a year That WAC cost to the insurer
My Repatha is roughly $100 a month to me ..but I have to self inject it every 2 weeks … sub Q
Current view is that NVS over paid for Inclirisan. Launch was delayed in the US and most insurers are refusing to cover I think based on cost
On a more upbeat note Kaiser just sent me another 400 caps of Brand Vascepa for $24 … their retail price is just over $1,000 for the same number of caps 100 days of V ( 4 caps a day ) for $24 What’s that ….24 c a day ? Chk my math …I’m having a beer to celebrate:—)
News 
Market Data 
Discover 
